Hester Biosciences Ltd

HESTERBIO
NSE· Healthcare
₹2,120.90
+18.70 (+0.89%)
Updated 12:31 pm IST
52W Low · ₹1,275.0052W High · ₹2,350.00
Near 52W High
Market Cap
₹1238.00L Cr
Volume
3.5K
Prev Close
₹2,102.20
ISIN
INE782E01017

Orion Score

Fundamentals-based quality & risk · not a recommendation

50/100
Watch

Hester Biosciences Ltd scores 50/100 (Watch) on the Orion Score — moderate business quality (52), moderate growth (59), weak balance-sheet safety (43) and fair valuation (42). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
52
Growth
59
Safety
43
Value
42

Full Orion analysis

Risk checks

  • Profit converts to cash (CFO 1.3× PAT)
  • Low debt, comfortable interest cover
  • No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(5.34)Beneish M Clean(-2.27)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

58/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Moderate
D/E 0.53x — manageable leverage
QUALITY
Average
ROCE 12.9% — decent returns
MOMENTUM
Neutral
RSI 59.1 — consolidating

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio
29.07
ROCE
12.90%
ROE (1Y)
16.56%
D/E Ratio
0.53x
OPM
28.39%
TTM EPS
₹67.48
Dividend Yield
36.00%
Qtrly Sales
₹100.11 Cr
Qtrly Profit
₹15.98 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q4 2026₹100.11₹15.9828.4%₹19.45
Q3 2026₹77.42₹8.7717.3%₹10.94
Q2 2026₹70.97₹14.4510.4%₹16.85
Q1 2026₹84.11₹16.4422.1%₹20.33
Q4 2025₹81.92₹1.2918.3%₹1.82

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2026₹332.6₹55.64₹105.6520.4%
FY 2025₹311.1₹27.49₹69.0814.2%
FY 2024₹304.55₹18.89₹58.2513.9%
FY 2023₹266.09₹26.63₹6615.6%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
HESTERBIO ★₹1,238 Cr29.0712.90%16.56%0.53x28.39%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹90,029 Cr25.9412.55%9.93%0.21x15.11%
ABBOTINDIA₹57,724 Cr36.6336.14%34.46%0.04x27.01%
AJANTPHARM₹41,836 Cr39.5527.99%25.39%0.06x51.40%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹653.38₹662.35₹669.97₹562.16
Equity₹314.25₹291.79₹279.73₹259.99
Total Debt₹213.25₹244.38₹274.15₹228.17
Cash₹5.59₹12.31₹12.67₹24.27
Net Debt₹202.19₹226.69₹255.32₹198.01
Working Capital₹69.99₹109.14₹78.9₹97.87

Shareholding Pattern

Q1 FY2027

Promoter
68.75%
FII
0.2%
DII
0.17%
Public
30.88%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202768.75% ↑0.2% ↓0.17% ↑30.88% ↓
Q3 FY202653.73%0.52% ↓0.01% ↑45.75% ↑
Q2 FY202653.73%0.53% ↑0% ↓45.73%
Q1 FY202653.73%0.51% ↓0.02%45.73% ↑
Q4 FY202553.73%0.87% ↑0.02%45.38% ↓
Q3 FY202553.73%0.59% ↓0.02% ↑45.65%
Q2 FY202553.73%0.61% ↑0%45.66% ↓
Q1 FY202553.73%0.52%0%45.74%

Corporate Actions

Ex-DateActionDetails
2026-07-14
DIVIDEND
Dividend - Rs 11 Per Share

Funds Holding This Stock

1 mutual fund schemes

1
Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.05%

₹0 Cr

Analyse HESTERBIO with Orion AI

Ask: "Is Hester Biosciences Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Hester Biosciences Ltd (HESTERBIO) Stock

Hester Biosciences Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE782E01017. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.